Neurocrine to Buy Soleno, Nabbing Drug for Relentless Hunger Disorder
The deal is the latest in a busy year for dealmaking in the biotech industry. – eric piermont/Agence…
This Healthcare Stock’s Revolutionary Drug Could Make Early Investors Rich
Summit Therapeutics’ leading candidate is showing promise in a key oncology market. The medicine could earn plenty of…